EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Immune response against toxoplasmosis—some recent updates RH: Toxoplasma gondii immune response

Madiha Sana, Muhammad Rashid, Imran Rashid iD, Haroon Akbar iD, Jorge E Gomez-Marin, Isabelle Dimier-Poisson

International Journal of Immunopathology and Pharmacology · 2022-04 · 36

DOI: 10.1177/03946320221078436 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Immunopathology and Pharmacology, online erschienen am 28.02.2022. Verfasst von Madiha Sana und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Parasitology, 66920University of Veterinary and Animal Sciences, Lahore, Pakistan. Hauptthemen laut MEDLINE: Toxoplasma, Toxoplasmosis. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 207 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Cytokines, soluble mediators of immunity, are key factors of the innate and adaptive immune system. They are secreted from and interact with various types of immune cells to manipulate host body’s immune cell physiology for a counter-attack on the foreign body. A study was designed to explore the mechanism of Toxoplasma gondii ( T. gondii) resistance from host immune response. Methods and results The published data on aspect of host (murine and human) immune response against T. gondii was taken from Google scholar and PubMed. Most relevant literature was included in this study. The basic mechanism of immune response starts from the interactions of antigens with host immune cells to trigger the production of cytokines (pro-inflammatory and anti-inflammatory) which then act by forming a cytokinome (network of cytokine). Their secretory equilibrium is essential for endowing resistance to the host against infectious diseases, particularly toxoplasmosis. A narrow balance lying between Th1, Th2, and Th17 cytokines (as demonstrated until now) is essential for the development of resistance against T. gondii as well as for the survival of host. Excessive production of pro-inflammatory cytokines leads to tissue damage resulting in the production of anti-inflammatory cytokines which enhances the proliferation of Toxoplasma. Stress and other infectious diseases (human immunodeficiency virus (HIV)) that weaken the host immunity particularly the cellular component, make the host susceptible to toxoplasmosis especially in pregnant women.

Conclusion

The current review findings state that in vitro harvesting of IL12 from DCs, Np and MΦ upon exposure with T. gondii might be a source for therapeutic use in toxoplasmosis. Current review also suggests that therapeutic interventions leading to up-regulation/supplementation of SOCS-3, IL12, and IFNγ to the infected host could be a solution to sterile immunity against T. gondii infection. This would be of interest particularly in patients passing through immunosuppression owing to any reason like the ones receiving anti-cancer therapy, the ones undergoing immunosuppressive therapy for graft/transplantation, the ones suffering from immunodeficiency virus (HIV) or having AIDS. Another imortant suggestion is to launch the efforts for a vaccine based on GRA6Nt or other similar antigens of T. gondii as a probable tool to destroy tissue cysts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ToxoplasmaToxoplasmosisAnimalsCytokinesFemaleHumansImmunityMicePregnancy

Stichwörter der Autor:innen

Toxoplasma gondiicytokinomeshost immune responsehost resistancesusceptibility

Substanzen

Cytokines

Autor:innen und Institutionen

  • Department of Parasitology, 66920University of Veterinary and Animal Sciences, Lahore, Pakistan.
  • Department of Parasitology, Faculty of Veterinary and Animal Sciences, 66920The Islamia University of Bahawalpur, Pakistan.
  • Grupo Gepamol, Centro de Investigaciones Biomedicas, Universidad del Quindio, Armenia, CO, South America.
  • Université de Tours, Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (INRAE), Unité mixte de recherche 1282 (UMR1282), Infectiologie et santé publique (ISP), Tours, France.

ORCID-Profile: Imran Rashid, Haroon Akbar

Zitieren

APA

Sana, M., Rashid, M., Rashid, I., Akbar, H., Gomez-Marin, J. E., & Dimier-Poisson, I. (2022). Immune response against toxoplasmosis—some recent updates RH: Toxoplasma gondii immune response. International Journal of Immunopathology and Pharmacology, 36. https://doi.org/10.1177/03946320221078436

Vancouver

Sana M, Rashid M, Rashid I, Akbar H, Gomez-Marin JE, Dimier-Poisson I. Immune response against toxoplasmosis—some recent updates RH: Toxoplasma gondii immune response. International Journal of Immunopathology and Pharmacology. 2022;36. doi:10.1177/03946320221078436

BibTeX
@article{Sana2022,
  author = {Sana, Madiha and Rashid, Muhammad and Rashid, Imran and Akbar, Haroon and Gomez-Marin, Jorge E and Dimier-Poisson, Isabelle},
  title = {Immune response against toxoplasmosis—some recent updates RH: Toxoplasma gondii immune response},
  journal = {International Journal of Immunopathology and Pharmacology},
  year = {2022},
  volume = {36},
  doi = {10.1177/03946320221078436}
}
Kostenlos starten →